Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease
about
The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brainIncreased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study.Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases.Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms.Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells.Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammationAdenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism.Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain.Adenosine receptors and epilepsy: current evidence and future potential.Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system.History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents.Caffeine and cardiovascular diseases: critical review of current research.How does adenosine control neuronal dysfunction and neurodegeneration?Different danger signals differently impact on microglial proliferation through alterations of ATP release and extracellular metabolism.Altered motility of plaque-associated microglia in a model of Alzheimer's disease.Adenosine A2A receptor regulation of microglia morphological remodeling-gender bias in physiology and in a model of chronic anxiety.Istradefylline reduces memory deficits in aging mice with amyloid pathology.Purinergic system in psychiatric diseases.Adenosine A2A Receptor Blockade Modulates Glucocorticoid-Induced Morphological Alterations in Axons, But Not in Dendrites, of Hippocampal Neurons.Caffeine and Modafinil Ameliorate the Neuroinflammation and Anxious Behavior in Rats during Sleep Deprivation by Inhibiting the Microglia Activation.Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy.Adenosine A2A Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges.Beneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's DiseasePolydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis
P2860
Q26824833-52F24838-F044-4A5A-B2AB-E49D5B80778FQ30873974-5695E2EC-7DC0-4B04-BA51-D31870ADF0A1Q34014053-E36800A2-14BA-4200-B86D-1FB7E3881CD2Q35025103-F56DF0FF-9942-449F-B840-9191792E3E5DQ35899431-29D99D77-C5CC-4380-A619-135E7369630EQ35993007-49B16053-CF47-4E5F-937D-1A27FE93BA8CQ36238937-9A174176-7871-4000-BF59-DE1A840FB4C3Q36627429-806D26C8-2119-426E-8C98-473F42D7C20BQ36892883-7B7C7314-2897-4989-AB2F-2FDFDDE881A9Q38245140-C44045F1-2048-487D-8620-9312D3BD9D3CQ38363863-CFE9702F-C09C-4269-96E7-FA952DB9E6F8Q38395423-CF20348A-CE2E-4A43-816D-AD2031326244Q38757122-21AC7F69-D3BC-4ABC-AB17-E37E7581A5E4Q38882782-8D6D811C-EC68-4F2F-9B86-EE02401C72AEQ38890301-E133A77B-1C5B-496D-8B46-D5F9CB612351Q42174672-FF68B2CF-014E-4DD9-A931-7DD796086844Q47386152-3DA9183F-8D58-4007-9B1F-F34B63C19DE9Q47443548-AD6200B3-E64A-4F05-A479-96D63EE0934AQ47758170-1A8A84D9-C568-41C1-8A4D-28AE622DAF0BQ52608764-7DF89A01-1D73-4CCE-B7BC-A48EC44B5E42Q52620604-6E0C7994-F628-448C-AA24-9F263891B4DEQ55266660-17D1FDFD-5B3B-451A-AE4F-31304856A40CQ55297865-E76CC189-30B4-4A58-BD47-2AF16CB3E690Q57896338-C8245526-2D5E-4C9F-AD5A-EC2B553CC628Q59130137-22ECC006-5411-4F91-B918-C23C6358DD35
P2860
Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Adenosine A2A receptor antagon ...... a model of Parkinson's disease
@ast
Adenosine A2A receptor antagon ...... a model of Parkinson's disease
@en
type
label
Adenosine A2A receptor antagon ...... a model of Parkinson's disease
@ast
Adenosine A2A receptor antagon ...... a model of Parkinson's disease
@en
prefLabel
Adenosine A2A receptor antagon ...... a model of Parkinson's disease
@ast
Adenosine A2A receptor antagon ...... a model of Parkinson's disease
@en
P2093
P2860
P921
P1476
Adenosine A2A receptor antagon ...... a model of Parkinson's disease
@en
P2093
Carlos Lazo
Ethel Garnier-Amblard
Lauren Shapiro
Stefka Gyoneva
Stephen F Traynelis
Yoland Smith
P2860
P304
P356
10.1016/J.NBD.2014.03.004
P577
2014-03-13T00:00:00Z